Literature DB >> 17200721

Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance.

Yasuo Terauchi1, Iseki Takamoto, Naoto Kubota, Junji Matsui, Ryo Suzuki, Kajuro Komeda, Akemi Hara, Yukiyasu Toyoda, Ichitomo Miwa, Shinichi Aizawa, Shuichi Tsutsumi, Yoshiharu Tsubamoto, Shinji Hashimoto, Kazuhiro Eto, Akinobu Nakamura, Mitsuhiko Noda, Kazuyuki Tobe, Hiroyuki Aburatani, Ryozo Nagai, Takashi Kadowaki.   

Abstract

Glucokinase (Gck) functions as a glucose sensor for insulin secretion, and in mice fed standard chow, haploinsufficiency of beta cell-specific Gck (Gck(+/-)) causes impaired insulin secretion to glucose, although the animals have a normal beta cell mass. When fed a high-fat (HF) diet, wild-type mice showed marked beta cell hyperplasia, whereas Gck(+/-) mice demonstrated decreased beta cell replication and insufficient beta cell hyperplasia despite showing a similar degree of insulin resistance. DNA chip analysis revealed decreased insulin receptor substrate 2 (Irs2) expression in HF diet-fed Gck(+/-) mouse islets compared with wild-type islets. Western blot analyses confirmed upregulated Irs2 expression in the islets of HF diet-fed wild-type mice compared with those fed standard chow and reduced expression in HF diet-fed Gck(+/-) mice compared with those of HF diet-fed wild-type mice. HF diet-fed Irs2(+/-) mice failed to show a sufficient increase in beta cell mass, and overexpression of Irs2 in beta cells of HF diet-fed Gck(+/-) mice partially prevented diabetes by increasing beta cell mass. These results suggest that Gck and Irs2 are critical requirements for beta cell hyperplasia to occur in response to HF diet-induced insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17200721      PMCID: PMC1716196          DOI: 10.1172/JCI17645

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families.

Authors:  G Velho; H Blanché; M Vaxillaire; C Bellanné-Chantelot; V C Pardini; J Timsit; P Passa; I Deschamps; J J Robert; I T Weber; D Marotta; S J Pilkis; G M Lipkind; G I Bell; P Froguel
Journal:  Diabetologia       Date:  1997-02       Impact factor: 10.122

Review 2.  Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance.

Authors:  K S Polonsky; J Sturis; G I Bell
Journal:  N Engl J Med       Date:  1996-03-21       Impact factor: 91.245

3.  Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease.

Authors:  Y Terauchi; K Iwamoto; H Tamemoto; K Komeda; C Ishii; Y Kanazawa; N Asanuma; T Aizawa; Y Akanuma; K Yasuda; T Kodama; K Tobe; Y Yazaki; T Kadowaki
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

4.  Disruption of IRS-2 causes type 2 diabetes in mice.

Authors:  D J Withers; J S Gutierrez; H Towery; D J Burks; J M Ren; S Previs; Y Zhang; D Bernal; S Pons; G I Shulman; S Bonner-Weir; M F White
Journal:  Nature       Date:  1998-02-26       Impact factor: 49.962

5.  The human glucokinase gene beta-cell-type promoter: an essential role of insulin promoter factor 1/PDX-1 in its activation in HIT-T15 cells.

Authors:  H Watada; Y Kajimoto; Y Umayahara; T Matsuoka; H Kaneto; Y Fujitani; T Kamada; R Kawamori; Y Yamasaki
Journal:  Diabetes       Date:  1996-11       Impact factor: 9.461

6.  Analysis of the pancreatic beta cell in the mouse with targeted disruption of the pancreatic beta cell-specific glucokinase gene.

Authors:  T Aizawa; N Asanuma; Y Terauchi; N Suzuki; M Komatsu; N Itoh; T Nakabayashi; H Hidaka; H Ohnota; K Yamauchi; K Yasuda; Y Yazaki; T Kadowaki; K Hashizume
Journal:  Biochem Biophys Res Commun       Date:  1996-12-13       Impact factor: 3.575

Review 7.  Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm.

Authors:  F M Matschinsky
Journal:  Diabetes       Date:  1996-02       Impact factor: 9.461

8.  Pancreatic beta-cell-specific targeted disruption of glucokinase gene. Diabetes mellitus due to defective insulin secretion to glucose.

Authors:  Y Terauchi; H Sakura; K Yasuda; K Iwamoto; N Takahashi; K Ito; H Kasai; H Suzuki; O Ueda; N Kamada
Journal:  J Biol Chem       Date:  1995-12-22       Impact factor: 5.157

9.  A variation at position -30 of the beta-cell glucokinase gene promoter is associated with reduced beta-cell function in middle-aged Japanese-American men.

Authors:  L M Stone; S E Kahn; W Y Fujimoto; S S Deeb; D Porte
Journal:  Diabetes       Date:  1996-04       Impact factor: 9.461

10.  beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes.

Authors:  U Ahlgren; J Jonsson; L Jonsson; K Simu; H Edlund
Journal:  Genes Dev       Date:  1998-06-15       Impact factor: 11.361

View more
  142 in total

1.  Insulin secretion and insulin-producing tumors.

Authors:  Jean-Marc Guettier; Phillip Gorden
Journal:  Expert Rev Endocrinol Metab       Date:  2010-03-01

2.  Development of novel cell lines of diabetic dysfunction model fit for cell-based screening tests of medicinal materials.

Authors:  Mikako Saito; Aya Hayakawa; Nobuya Inagaki; Hideaki Matsuoka
Journal:  Cytotechnology       Date:  2012-07-10       Impact factor: 2.058

3.  In vivo targeted delivery of ANGPTL8 gene for beta cell regeneration in rats.

Authors:  Jiaxi Chen; Shuyuan Chen; Pintong Huang; Xing-Li Meng; Sandra Clayton; Jin-Song Shen; Paul A Grayburn
Journal:  Diabetologia       Date:  2015-02-28       Impact factor: 10.122

4.  Pancreatic duct ligation after almost complete β-cell loss: exocrine regeneration but no evidence of β-cell regeneration.

Authors:  Claudia Cavelti-Weder; Maria Shtessel; Joshua E Reuss; Agnes Jermendy; Takatsugu Yamada; Francisco Caballero; Susan Bonner-Weir; Gordon C Weir
Journal:  Endocrinology       Date:  2013-09-12       Impact factor: 4.736

5.  High Fat Diet Regulation of β-Cell Proliferation and β-Cell Mass.

Authors:  M L Golson; A Ackermann Misfeldt; U G Kopsombut; C P Petersen; M Gannon
Journal:  Open Endocrinol J       Date:  2010

6.  A dominant role for glucose in beta cell compensation of insulin resistance.

Authors:  Gordon C Weir; Susan Bonner-Weir
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

7.  Characterization of the heterozygous glucokinase knockout mouse as a translational disease model for glucose control in type 2 diabetes.

Authors:  D J Baker; A M Atkinson; G P Wilkinson; G J Coope; A D Charles; B Leighton
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 8.  Advances in β cell replacement and regeneration strategies for treating diabetes.

Authors:  Jacqueline R Benthuysen; Andrea C Carrano; Maike Sander
Journal:  J Clin Invest       Date:  2016-10-03       Impact factor: 14.808

9.  Successful β cells islet regeneration in streptozotocin-induced diabetic baboons using ultrasound-targeted microbubble gene therapy with cyclinD2/CDK4/GLP1.

Authors:  Shuyuan Chen; Raul A Bastarrachea; Brad J Roberts; V Saroja Voruganti; Patrice A Frost; Edna J Nava-Gonzalez; Hector E Arriaga-Cazares; Jiaxi Chen; Pintong Huang; Ralph A DeFronzo; Anthony G Comuzzie; Paul A Grayburn
Journal:  Cell Cycle       Date:  2014-02-10       Impact factor: 4.534

10.  Inhibition of Small Maf Function in Pancreatic β-Cells Improves Glucose Tolerance Through the Enhancement of Insulin Gene Transcription and Insulin Secretion.

Authors:  Hiroshi Nomoto; Takuma Kondo; Hideaki Miyoshi; Akinobu Nakamura; Yoko Hida; Ken-ichiro Yamashita; Arun J Sharma; Tatsuya Atsumi
Journal:  Endocrinology       Date:  2015-03-12       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.